Veru (VERU) Other Working Capital Changes (2013 - 2026)
Veru (VERU) posted quarterly Other Working Capital Changes of $546991.0 for Q3 2025, up 531.93% year-over-year from $86558.9 in Q3 2024, and up 505.84% quarter-over-quarter from -$134780.0 in Q2 2025.
Veru (VERU) Other Working Capital Changes (2013 - 2026) Analysis & Trends
Veru (VERU) has reported Other Working Capital Changes for 10 consecutive years, with $546991.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Other Working Capital Changes rose 531.93% year-over-year to $546991.0; the TTM figure through Mar 2026 stood at $412211.0 (up 161.31% YoY), while the FY2025 annual figure was $58812.0, up 108.6% from the prior year.
- Other Working Capital Changes climbed to $546991.0 in Q3 2025 per VERU's latest filing, from -$134780.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $1.3 million in Q4 2023 and bottomed at -$3.4 million in Q2 2023.
- Historically, Other Working Capital Changes has averaged -$854045.1 across 5 years, with a median of -$646250.0 in 2025.
- Annual changes were most pronounced in 2021 — Other Working Capital Changes sank 12552.02% — and 2025, when it soared 531.93%.
- Veru's Other Working Capital Changes stood at -$52776.0 in 2021, then surged by 105.53% to $2921.0 in 2022, then slumped by 5951.9% to -$170934.0 in 2023, then slumped by 31.44% to -$224676.0 in 2024, then soared by 343.46% to $546991.0 in 2025.
- Business Quant data shows VERU's Other Working Capital Changes at $546991.0 in Q3 2025, -$134780.0 in Q2 2025, and -$128723.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - |
| 10 | Veru | 60.90 Mn | 35.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.15 Mn |
| Jun 30, 2026 | -1.15 Mn |
| Jun 30, 2026 | -1.15 Mn |
| Mar 31, 2026 | 310,553.00 |
| Mar 31, 2026 | 310,553.00 |
| Mar 31, 2026 | 310,553.00 |
| Dec 31, 2025 | 814,821.00 |
| Dec 31, 2025 | 814,821.00 |
| Dec 31, 2025 | 814,821.00 |
| Sep 30, 2025 | -646,250.00 |
| Sep 30, 2025 | -646,250.00 |
| Sep 30, 2025 | -646,250.00 |
| Jun 30, 2025 | -93,245.00 |
| Jun 30, 2025 | -93,245.00 |
| Jun 30, 2025 | -93,245.00 |
| Mar 31, 2025 | -169,116.00 |
| Mar 31, 2025 | -169,116.00 |
| Mar 31, 2025 | -169,116.00 |
| Dec 31, 2024 | 511,038.00 |
| Dec 31, 2024 | 511,038.00 |